Bisoprolol fumarate and Aprepitant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bisoprolol fumarate (bisoprolol fumarate) and Aprepitant (aprepitant). Common drug interactions include ventricular dysfunction among females and cholangitis acute among males.

The phase IV clinical study analyzes what interactions people have when they take Bisoprolol fumarate and Aprepitant. It is created by eHealthMe based on reports of 89 people who take the same drugs from the FDA, and is updated regularly.

What is Bisoprolol fumarate?

Bisoprolol fumarate has active ingredients of bisoprolol fumarate. It is often used in high blood pressure. eHealthMe is studying from 40,828 Bisoprolol fumarate users. Check the latest studies of Bisoprolol fumarate.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

On Jul, 10, 2026

89 people who take Bisoprolol fumarate and Aprepitant together, and have interactions are studied.

Bisoprolol fumarate and Aprepitant drug interactions.

What are the common drug interactions of Bisoprolol Fumarate and Aprepitant, by gender? *:

female:

Ventricular dysfunction (heart dysfunction)
Nausea (feeling of having an urge to vomit)
White blood cell count decreased
Thrombocytopenia (decrease of platelets in blood)
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
Skin fissures (a crack in the skin)
Diarrhoea
Interstitial lung disease
Rash
Somnolence (a state of near-sleep, a strong desire for sleep)

male:

Cholangitis acute (rapid infection of bile duct)
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Neutropenia (an abnormally low number of neutrophils)
Splenic infarction (tissue damage of spleen)
Klebsiella infection
Oxygen saturation decreased
Platelet count decreased
Proteus infection (proteus can cause urinary tract infections)
Respiratory distress (difficulty in breathing)

What are the common drug interactions of Bisoprolol Fumarate and Aprepitant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

White blood cell count decreased
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
Nausea (feeling of having an urge to vomit)
Skin fissures (a crack in the skin)
Thrombocytopenia (decrease of platelets in blood)
Diplopia (double vision)
Mononeuropathy multiplex (a form of damage to one or more peripheral nerves -- the nerves outside the brain and spinal cord)

40-49:

White blood cell count decreased
Thrombocytopenia (decrease of platelets in blood)
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
Nausea (feeling of having an urge to vomit)
Skin fissures (a crack in the skin)
Influenza

50-59:

Aplasia (defective development or congenital absence of an organ or tissue)
Stomatitis (inflammation of mucous membrane of mouth)
Myelosuppression (a decrease in the production of blood cells)
Splenic infarction (tissue damage of spleen)
Procedural pain
Urinary tract infection

60+:

Cholangitis acute (rapid infection of bile duct)
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins)
Neutropenia (an abnormally low number of neutrophils)
Somnolence (a state of near-sleep, a strong desire for sleep)
Klebsiella infection
Left ventricular dysfunction
Oxygen saturation decreased
Platelet count decreased
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
Proteus infection (proteus can cause urinary tract infections)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 16 people, 17.98%
Diarrhea: 13 people, 14.61%
Lung Cancer - Non-Small Cell (lung cancer): 13 people, 14.61%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 12 people, 13.48%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 12 people, 13.48%
Type 2 Diabetes: 9 people, 10.11%
Breast Cancer Metastatic: 9 people, 10.11%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 9 people, 10.11%
Dyslipidaemia (abnormal amount of lipids): 8 people, 8.99%
Headache (pain in head): 8 people, 8.99%

* Approximation only. Some reports may have incomplete information.

Do you take Bisoprolol fumarate and Aprepitant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously